TipRanks
Advertisement
Advertisement
Enlivex Therapeutics target adjusted to $80 from $20 at H.C. Wainwright
PremiumThe FlyEnlivex Therapeutics target adjusted to $80 from $20 at H.C. Wainwright
2M ago
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million
Premium
Company Announcements
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million
3M ago
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone
Premium
Company Announcements
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone
3M ago
Enlivex Wins FDA RMAT Status for Allocetra in Age-Related Knee Osteoarthritis
PremiumCompany AnnouncementsEnlivex Wins FDA RMAT Status for Allocetra in Age-Related Knee Osteoarthritis
3M ago
Enlivex Therapeutics receives RMAT designation for Allocetra from FDA
Premium
The Fly
Enlivex Therapeutics receives RMAT designation for Allocetra from FDA
3M ago
Enlivex Therapeutics trading halted, news pending
Premium
The Fly
Enlivex Therapeutics trading halted, news pending
3M ago
Enlivex Therapeutics announces issuance of Australian patent
PremiumThe FlyEnlivex Therapeutics announces issuance of Australian patent
4M ago
Enlivex Values RAIN Token Treasury at $1.16 Billion as Rain Protocol Climbs to No. 3 in Prediction Markets
Premium
Company Announcements
Enlivex Values RAIN Token Treasury at $1.16 Billion as Rain Protocol Climbs to No. 3 in Prediction Markets
5M ago
Enlivex comments on $100M commitment to Rain’s prediction market
Premium
The Fly
Enlivex comments on $100M commitment to Rain’s prediction market
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―